Philip L. Regan

Bath, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 16 publications

Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis.

Epigallocatechin Gallate Modulates Microglia Phenotype to Suppress Pro-inflammatory Signalling Cues and Inhibit Phagocytosis.

Journal: Molecular neurobiology
Published: June 13, 2023

Regulation of Synapse Weakening through Interactions of the Microtubule Associated Protein Tau with PACSIN1.

Regulation of Synapse Weakening through Interactions of the Microtubule Associated Protein Tau with PACSIN1.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: December 14, 2020

The Role of Tau in the Post-synapse.

The Role of Tau in the Post-synapse.

Journal: Advances in experimental medicine and biology
Published: February 26, 2020

Postsynaptic p47phox regulates long-term depression in the hippocampus.

Postsynaptic p47phox regulates long-term depression in the hippocampus.

Journal: Cell discovery
Published: December 08, 2017

Impairment of Release Site Clearance within the Active Zone by Reduced SCAMP5 Expression Causes Short-Term Depression of Synaptic Release.

Impairment of Release Site Clearance within the Active Zone by Reduced SCAMP5 Expression Causes Short-Term Depression of Synaptic Release.

Journal: Cell reports
Published: August 17, 2017

Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.

Dendritic spine anomalies and PTEN alterations in a mouse model of VPA-induced autism spectrum disorder.

Journal: Pharmacological research
Published: July 14, 2017

Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus.

Glucocorticoids activate a synapse weakening pathway culminating in tau phosphorylation in the hippocampus.

Journal: Pharmacological research
Published: March 31, 2017

Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease.

Ca2+-permeable AMPA receptor: A new perspective on amyloid-beta mediated pathophysiology of Alzheimer's disease.

Journal: Neuropharmacology
Published: June 01, 2016

Physiological and Pathophysiological Implications of Synaptic Tau.

Physiological and Pathophysiological Implications of Synaptic Tau.

Journal: The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry
Published: February 25, 2016

Tau phosphorylation at serine 396 residue is required for hippocampal LTD.

Tau phosphorylation at serine 396 residue is required for hippocampal LTD.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: March 27, 2015

Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus.

Intracellular oligomeric amyloid-beta rapidly regulates GluA1 subunit of AMPA receptor in the hippocampus.

Journal: Scientific reports
Published: February 17, 2015

Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP.

Cyclin Y inhibits plasticity-induced AMPA receptor exocytosis and LTP.

Journal: Scientific reports
Published: February 10, 2015
Showing 1-12 of 16

Last Updated: 09/26/2026